Merit Financial Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Merit Financial Group's ADPT Position: Q3 2026 in Review
Merit Financial Group reduced its Adaptive Biotechnologies (ADPT) stake by 11% in Q3 2026, selling an estimated $60.1K and leaving 19,883 shares worth $575K. The position accounts for ﹤0.01% of the portfolio, ranked #1493.
Merit Financial Group first reported a position in ADPT in Q2 2026 and has held it in 2 quarters since. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- Merit Financial Group held 19,883 shares of Adaptive Biotechnologies worth $575K as of Q3 2026.
- Merit Financial Group sold 2,447 Adaptive Biotechnologies shares in Q3 2026, an estimated $60.1K.
- Adaptive Biotechnologies made up ﹤0.01% of Merit Financial Group's portfolio in Q3 2026, its #1493 holding.
- Merit Financial Group first reported a position in Adaptive Biotechnologies in Q2 2026 and has held it in 2 quarters since.
- 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on Merit Financial Group's 13F filing for Q3 2026, filed 6 Nov 2026.